Trial intelligence / Profile preview

Abuse Potential of Ramelteon vs Triazolam in Subjects with History of Polydrug Abuse

NCT00671632Phase 2Completed

Sponsor
Takeda
Start
Jun 2003
Primary completion
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ramelteon in Insomnia, sponsored by Takeda. Started Jun 2003; status: completed.

02

Drugs

ramelteon
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00671632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00671632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call